The serum lipid profile of Parkinson's disease patients: a study from China

Discontinuation of statin therapy associates with Parkinson disease: A population-based study

(2013) Y.-C. Lee et al.   NEUROLOGY

Nutritional status and dietary habits in Parkinson’s disease patients in Ghana

(2013) Michela Barichella et al.   NUTRITION

Cardiometabolic factors and disease duration in patients with Parkinson’s disease

(2013) Erica Cassani et al.   NUTRITION

Prospective Study of Statin Use and Risk of Parkinson Disease

(2012) Xiang Gao   ARCHIVES OF NEUROLOGY

Low cardiometabolic risk in Parkinson's disease is independent of nutritional status, body composition and fat distribution

(2012) Emanuele Cereda et al.   CLINICAL NUTRITION

Metabolic markers or conditions preceding Parkinson's disease: A case-control study

(2012) Rodolfo Savica et al.   MOVEMENT DISORDERS

The fusogenic tilted peptide (67–78) of α-synuclein is a cholesterol binding domain

(2011) Jacques Fantini et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Diabetes and Risk of Parkinson's Disease: A systematic review and meta-analysis

(2011) E. Cereda et al.   DIABETES CARE

The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors-relevance to Parkinson’s disease

(2011) Gurdeep Marwarha et al.   JOURNAL OF NEUROCHEMISTRY

Serological Profiles of Urate, Paraoxonase-1, Ferritin and Lipid in Parkinson’s Disease: Changes Linked to Disease Progression

(2011) Ken Ikeda et al.   Neurodegenerative Diseases

Anthropometric indices of fat distribution and cardiometabolic risk in Parkinson’s disease

(2011) E. Cereda et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Dietary intake and olfactory function in patients with newly diagnosed Parkinson's disease: a case-control study

(2011) Emma Ådén et al.   NUTRITIONAL NEUROSCIENCE

Serum Cholesterol and the Progression of Parkinson's Disease: Results from DATATOP

(2011) Xuemei Huang et al.   PLoS One

Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan

(2010) Yoshihiro Miyake et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Statin use and Parkinson's disease in Denmark

(2010) Beate Ritz et al.   MOVEMENT DISORDERS

Combination therapy with Coenzyme Q10and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases

(2009) Lichuan Yang et al.   JOURNAL OF NEUROCHEMISTRY

Lipid-lowering drugs are associated with delayed onset and slower course of Parkinson's disease

(2009) Eugénie Mutez et al.   PHARMACOLOGICAL RESEARCH

Use of Statins and the Risk of Parkinson???s Disease

(2008) Claudia Becker et al.   DRUG SAFETY

Statin use and the risk of Parkinson disease: a nested case control study

(2008) Ali Samii et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Statins reduce neuronal α-synuclein aggregation in in vitro models of Parkinson’s disease

(2008) Pazit Bar-On et al.   JOURNAL OF NEUROCHEMISTRY

Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study

(2008) Xuemei Huang et al.   MOVEMENT DISORDERS

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS

Statin use and the risk of Parkinson disease

(2008) A. D. Wahner et al.   NEUROLOGY

Total cholesterol and the risk of Parkinson disease

(2008) G. Hu et al.   NEUROLOGY

Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease

(2008) Giulio Scigliano et al.   PARKINSONISM & RELATED DISORDERS